Elite Pharmaceuticals Inc (ELTP)

[Couch]

One must accept this company for what it is: a penny stock. The market is slow in forgiving for prior management errors. However,if this company had true underlying intrinsic value, the shares would have received sponsorship support, and would never have dropped and stayed at these low levels

You are certainly correct that the market is slow to forgive and even slower to forgive penny stocks that once were "destined" for greater things. Thus, Elite gets punished on two fronts for previous management errors. One from Wall Streets reservations and the second from the never ending manipulation that transpires on the OTC as a whole. So I think the question becomes what would allow Elite to be "forgiven"?

I think the answer lies in the intrinsic value you raise. The premise is that if Elite had intrinsic value to begin with it would've already received sponsorship support and never dropped to these levels. So should Elite launch Eli 200 in 2016 and get that illusive sponsorship support in the process does that mean Elite had intrinsic value all along? How about if Elite gets bought out in 2017 as I think it will.

I'm told several pharmaceutical companies have actually been in discussions with Elite's CEO to discuss that very sponsorship support. Am I to take that as evidence that Elite may in the end have this very illusive intrinsic value? After all, Purdue Pharmaceuticals itself came knocking back in 2004 to discuss a potential partnership with Elite and Alpharma. And I can more than easily discuss as I have previously why Purdue did not partner with Elite still highlighting the intrinsic value that Elite holds.

I could also discuss why Elite holds 5 times the intrinsic value that it did prior to Elite being delisted from the AMEX. Let's just say one would want to start with previous management having zero revenue base and not having been given a single abuse deterrent technology patent previously. Alpharma was bought out in large part do to its Intellectual Property Rights that it had already garnered prior to King buying them.

I'd say Elite has an abundance of intrinsic value and that is exactly why Nasrat a 30 year veteran in the Big Leagues decided to become Elite's CEO in the first place. No way in hell if Elite did not have a ton of intrinsic value that he would risk his becoming a CEO of a penny stock.

In the end we will see. I'm betting on Nasrat launching Eli 200 in 2016. The FDA giving Elite's its guidance on the matter tells me Elite has a rather solid chance of doing so. And if it does Wall Street will pay witness to Elite's intrinsic value.